Everolimus Eluting Coronary Stent System - India CDSCO Medical Device Registration

Everolimus Eluting Coronary Stent System is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID MFG/MD/2022/000680_c87d460d00d3564b32bb8aea8cee3662_97ae72bf239a35de9c8ca7590ca686f6. This device is marketed under the brand name Eternia-AB. The license holder is Innvolution Healthcare Pvt. Ltd., and it is classified as Device Class Class D. The approving authority is CDSCO -North Zone, Ghaziabad.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database

CDSCO Registered

Class Class D

Everolimus Eluting Coronary Stent System

UID: MFG/MD/2022/000680_c87d460d00d3564b32bb8aea8cee3662_97ae72bf239a35de9c8ca7590ca686f6

Brand Name

Eternia-AB

License Holder

Innvolution Healthcare Pvt. Ltd.

Device Class

Class D

Approving Authority

CDSCO -North Zone, Ghaziabad

Product Information

Everolimus Eluting Coronary Stent system (Eternia-AB) is intended for use in the patient eligible for Percutaneous Transluminal Coronary Angioplasty (Eternia-AB). Everolimus Eluting Coronary Stent System is indicated for improving coronary luminal diameter in patients with symptomatic ischemic disease due to discrete de novo lesions of length ≤ 48 mm in native coronary arteries with a reference vessel diameter of 2.00 to 4.50 mm